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The Editorial on the Research Topic
New Translational Insights on Metabolic Syndrome: Obesity, Hypertension, Diabetes, and
Beyond
Metabolic syndrome (MetS) can be considered as the clustering of several risk factors such as
obesity, hypertension, insulin resistance, and dyslipidemia, which could lead to the development
of diabetes and cardiovascular diseases (CVD). The criteria for clinical diagnosis of MetS consist
of 3 or more of the following: (1) waist circumference >102 cm in men and 88 cm in women;
(2) triglycerides >150 mg/dL; (3) HDL <40 mg/dL in men and <50 mg/dL in women; (4) blood
pressure ≥ 130/85 mmHg; (5) fasting glucose ≥ 100 mg/dL. Considering that the underlying
mechanisms leading to the concurrence of these factors are not yet well-established, the aim of
this research topic was to provide a space where researchers holding different backgrounds could
shed some light onto the pathophysiology of different risk factors involved in MetS.
The present research topic involves eleven articles including both reviews and original
manuscripts. In a translational perspective, the topic includes both clinical and experimental
approaches from different research groups located in several countries, which discuss different
aspects of MetS such as hypertension, obesity, diabetes, atherosclerosis, and inflammation. At the
present moment, almost 3000 article downloads were performed from researchers all over the
world. In this editorial, we highlight important insights from these articles leading to a better
comprehension of MetS and its complications.
Interestingly, in one aspect of metabolic disorders, the review articles by Costa-Silva et al. and
Silva et al. discuss the effects of malnutrition on the establishment of hypertension. Using an in
utero perspective, Costa-Silva et al. evaluate the effects of maternal malnutrition during pregnancy
on sympathetic-respiratory dysfunction that leads to hypertension. It has been shown that maternal
low-protein diet during gestation negatively affects organ growth and increases sympathetic tone
in the offspring. In addition, Silva et al. focus on post-weaning protein malnutrition and its
cardiovascular implications. Authors demonstrated that post-weaning low protein intake impairs
cardiovascular reflexes, increases sympathetic tonus, decreases vagal tonus, and enhances arterial
blood pressure and heart rate. Both groups agree that increased hypoxia-inducible factor expression
in malnutrition is responsible for the enhanced sympathoexcitation arising from chemoreflex
activation.
Opposite to malnutrition, obesity was discussed in three independent articles. As highlighted
by Del Rio et al., most efforts to understand MetS have been focused on the study of
peripheral organ malfunction, while the role of the nervous system on alterations observed
in MetS remains poorly understood. Focusing on central mechanisms involved in MetS,
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Moreira et al., Cruz et al., and Del Rio et al., independently
discussed the impact of increased sympathetic activity in
obesity. Moreira et al. provided us with a substantial review
of important MetS components such as obesity, hypertension,
insulin resistance, dyslipidemia, and inflammation. The link
between obesity and cardiovascular damage may reside on
leptin, since this peptide can increase sympathetic renal activity,
reactive oxygen species (ROS) in kidney and reduce nitric
oxide and that hyperleptinemia is a common feature in obesity.
Regarding central nervous system alterations in MetS, Cruz et al.
documented that the sympathoexcitation caused by peripheral
Ang II-induced ROS formation along the subfornical organ
(SFO) and paraventricular nucleus of the hypothalamus (PVN)
may be a putative mechanism to explain the metabolic disorders
underlying MetS. Lastly, Del Rio et al. bring a different approach
and focus their work on glial cells within central nuclei involved
in sympathetic control and how these cells could contribute to
the pathogenesis of MetS.
Metabolic syndrome is also involved in impairment of
glycemic control and end-organ damage. Therefore, Peleli
et al. studied the effects of inorganic nitrate on glucose
and insulin signaling in an experimental model of MetS
(adenosine receptor type A2B knockout mice, A
−/−
2B ). Acute
nitrate administration to A
−/−
2B mice resulted in ameliorated
glucose tolerance, reduced HOMA-IR and increased plasma
nitrate. Authors suggested that impaired AMP-activated kinase
(AMPK) activation and increased NADPH oxidase in liver
could contribute to MetS in this model, since the ratio of
phosphorylated/non-phosphorylated AMPK was reduced and
NADPH oxidase activity was increased in liver of A
−/−
2B mice.
Considering that diabetic nephropathy is an important cause
of death among diabetic patients, Gomes et al. proposed that a
low-dose of the antioxidant quercetin could improve metabolic
parameters and renal function in an experimental model
of diabetes and atherosclerosis (apolipoprotein E knockout—
apoE−/−—diabetic mouse). Furthermore, Arsenijevic et al.
propose that a primary reduction in kidney function can be
considered the cause of a pro-inflammatory and pro-oxidative
status, leading to metabolic disorders.
Lastly, three independent research groups focused their work
on the implications of inflammation in different determinants
of MetS. Firstly, Freitas Lima et al. discussed the influence of
adipokines in insulin resistance and atherosclerosis focusing
on adiponectin, TNF-α, IL-6, MCP-1, and leptin. Considering
that endothelial dysfunction is a sine qua non condition
to atherosclerosis development, the comprehension of this
phenomenon can create a window of opportunities for preventive
measures. Is this regard, Kraemer-Aguiar et al. discussed the
hypothesis that, as obesity is a multiple grade disease, an
increasing impairment of vascular function would occur from
lean to severe obese subjects. Using a different perspective,
Cavalcante-Silva et al. discussed the influence of gut microbiota
in inflammation and MetS. Authors provide us with a broad
review on normal gut microbiota and how it can modulate
adiposity, glucose homeostasis, fat accumulation, and other
metabolic pathways.
In conclusion, we found that this research topic, devoted to a
better understanding of MetS, and its associated comorbidities,
was very enlightening. We would to like to thank all authors and
reviewers that helped us to provide a quality-based topic.
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